BW Gestao de Investimentos Ltda. Sells 68,560 Shares of Tenet Healthcare Corporation $THC

BW Gestao de Investimentos Ltda. lessened its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 16.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 357,435 shares of the company’s stock after selling 68,560 shares during the quarter. Tenet Healthcare comprises about 1.6% of BW Gestao de Investimentos Ltda.’s investment portfolio, making the stock its 7th biggest position. BW Gestao de Investimentos Ltda.’s holdings in Tenet Healthcare were worth $71,029,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Wedmont Private Capital grew its position in Tenet Healthcare by 2.5% during the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after acquiring an additional 50 shares during the period. Baron Wealth Management LLC lifted its stake in shares of Tenet Healthcare by 4.8% in the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after acquiring an additional 52 shares in the last quarter. Sagespring Wealth Partners LLC raised its stake in Tenet Healthcare by 3.6% during the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after buying an additional 55 shares in the last quarter. Crestwood Advisors Group LLC grew its holdings in shares of Tenet Healthcare by 2.5% during the third quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company’s stock valued at $529,000 after purchasing an additional 64 shares during the last quarter. Finally, Signaturefd LLC grew its holdings in Tenet Healthcare by 9.0% in the 4th quarter. Signaturefd LLC now owns 798 shares of the company’s stock worth $159,000 after buying an additional 66 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of research reports. Leerink Partners increased their price target on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a research note on Friday, February 20th. Mizuho increased their target price on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Weiss Ratings restated a “buy (b-)” rating on shares of Tenet Healthcare in a report on Friday, March 27th. Truist Financial increased their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Finally, Robert W. Baird dropped their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Nineteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $244.16.

Tenet Healthcare Stock Down 3.2%

Shares of THC opened at $169.66 on Tuesday. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a 50-day moving average price of $189.23 and a two-hundred day moving average price of $201.72. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The stock has a market cap of $14.61 billion, a price-to-earnings ratio of 8.82, a P/E/G ratio of 1.15 and a beta of 1.28.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter in the previous year, the company posted $4.36 earnings per share. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts predict that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 23,138 shares of company stock worth $4,976,589 over the last quarter. 0.97% of the stock is currently owned by insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.